Background: The appetite-stimulating hormone ghrelin is a fundamental regulator of human energy metabolism. A series of studies support the notion that long-term appetite and weight regulation may be already programmed in early life and it could be demonstrated that the intrauterine environment affects the ghrelin system of the offspring. Animal studies have also shown that intrauterine programming of orexigenic systems persists even until adolescence/adulthood. Methods: We hypothesized that plasma ghrelin concentrations in adulthood may be associated with the intrauterine exposure to cigarette smoke. We examined this hypothesis in a sample of 19-year-olds followed up since birth in the framework of the Mannheim Study of Children at Risk, an ongoing epidemiological cohort study of the long-term outcome of early risk factors. Results: As a main finding, we found that ghrelin plasma concentrations in young adults who had been exposed to cigarette smoke in utero were significantly higher than in those without prenatal smoke exposure. Moreover, individuals with intrauterine nicotine exposure showed a significantly higher prevalence of own smoking habits and lower educational status compared to those in the group without exposure. Conclusion: Smoking during pregnancy may be considered as an adverse intrauterine influence that may alter the endocrine-metabolic status of the offspring even until early adulthood.

Keywords:
Cigarette smoke, Depression, Energy metabolism, Epigenetics, Ghrelin, Intrauterine exposure, Nicotine
1.
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660.
2.
Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992.
3.
Broglio F, Prodam F, Me E, Riganti F, Lucatello B, Granata R, Benso A, Muccioli G, Ghigo E: Ghrelin: endocrine, metabolic and cardiovascular actions (review). J Endocrinol Invest 2005;28(5 suppl):23-25.
4.
Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature 2000;407:908-913.
5.
Wren AM, Small CJ, Fribbens CV, Neary NM, Ward HL, Seal LJ, Ghatei MA, Bloom SR: The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 2002;76:316-324.
6.
Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, Suda M, Koh T, Natsui K, Toyooka S, Shirakami G, Usui T, Shimatsu A, Doi K, Hosoda H, Kojima M, Kangawa K, Nakao K: Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001;86:4753-4758.
7.
Purnell JQ, Weigle DS, Breen P, Cummings DE: Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 2003;88:5747-5752.
8.
Espelund U, Hansen TK, Højlund K, Beck-Nielsen H, Clausen JT, Hansen BS, Orskov H, Jørgensen JO, Frystyk J: Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects. J Clin Endocrinol Metab 2005;90:741-746.
9.
Cummings DE: Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav 2006;89:71-84.
10.
Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, Heiman ML, Lehnert P, Fichter M, Tschöp M: Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001;145:669-673.
11.
Tanaka M, Naruo T, Muranaga T, Yasuhara D, Shiiya T, Nakazato M, Matsukura S, Nozoe S: Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur J Endocrinol 2002;146:R1-R3.
12.
Tanaka M, Naruo T, Yasuhara D, Tatebe Y, Nagai N, Shiiya T, Nakazato M, Matsukura S, Nozoe S: Fasting plasma ghrelin levels in subtypes of anorexia nervosa. Psychoneuroendocrinology 2003;28:829-835.
13.
Fall CHD: Evidence for the intra-uterine programming of adiposity in later life. Ann Hum Biol 2011;38:410-428.
14.
Velkoska E, Morris M: Mechanisms behind early life nutrition and adult disease outcome. World J Diabetes 2011;2:127-132.
15.
Entringer S, Buss C, Swanson JM, Cooper DM, Wing DA, Waffarn F, Wadhwa PD: Fetal programming of body composition, obesity, and metabolic function: the role of intrauterine stress and stress biology. J Nutr Metab 2012;2012:632548.
16.
Larnkjaer A, Schack-Nielsen L, Mølgaard C, Ingstrup HK, Holst JJ, Michaelsen KF: Effect of growth in infancy on body composition, insulin resistance, and concentration of appetite hormones in adolescence. Am J Clin Nutr 2010;91:1675-1683.
17.
Smith J, Cianflone K, Biron S, Hould FS, Lebel S, Marceau S, Lescelleur O, Biertho L, Simard S, Kral JG, Marceau P: Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity. J Clin Endocrinol Metab 2009;94:4275-4283.
18.
Bossenmeyer-Pourié C, Blaise S, Pourié G, Tomasetto C, Audonnet S, Ortiou S, Koziel V, Rio MC, Daval JL, Guéant JL, Beck B: Methyl donor deficiency affects fetal programming of gastric ghrelin cell organization and function in the rat. Am J Pathol 2010;176:270-277.
19.
Siedlinski M, Klanderman B, Sandhaus RA, Barker AF, Brantly ML, Eden E, McElvaney NG, Rennard SI, Stocks JM, Stoller JK, Strange C, Turino GM, Campbell EJ, Demeo DL: Association of cigarette smoking and CRP levels with DNA methylation in α-1 antitrypsin deficiency. Epigenetics 2012;7:720-728.
20.
Wan ES, Qiu W, Baccarelli A, Carey VJ, Bacherman H, Rennard SI, Agusti A, Anderson W, Lomas DA, Demeo DL: Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. Hum Mol Genet 2012;21:3073-3082.
21.
Saad A, Abbas OA: Ghrelin as a regulator of gonadal function in adult male offsprings exposed to cigarette smoking in utero. Endocr Regul 2009;43:141-148.
22.
Bouhours-Nouet N, Boux de Casson F, Rouleau S, Douay O, Mathieu E, Bouderlique C, Gillard P, Limal JM, Descamps P, Coutant R: Maternal and cord blood ghrelin in the pregnancies of smoking mothers: possible markers of nutrient availability for the fetus. Horm Res 2006;66:6-12.
23.
Nagata E, Nakagawa Y, Yamaguchi R, Fujisawa Y, Sano S, Satake E, Matsushita R, Nakanishi T, Liu Y, Ohzeki T: Altered gene expressions of ghrelin, PYY, and CCK in the gastrointestinal tract of the hyperphagic intrauterine growth restriction rat offspring. Horm Metab Res 2011;43:178-182.
24.
Yousheng J, Nguyen T, Desai M, Ross MG: Programmed alterations in hypothalamic neuronal orexigenic responses to ghrelin following gestational nutrient restriction. Reprod Sci 2008;15:702-709.
25.
Laucht M, Esser G, Baving L, Gerhold M, Hoesch I, Ihle W, Steigleider P, Stock B, Stoehr RM, Weindrich D, Schmidt MH: Behavioral sequelae of perinatal insults and early family adversity at 8 years of age. J Am Acad Child Adolesc Psychiatry 2000;39:1229-1237.
26.
Laucht M, Esser G, Schmidt MH: Developmental outcome of infants born with biological and psychosocial risks. J Child Psychol Psychiatry 1997;38:843-853.
27.
Müller R, Abbet JP: Changing trends in the consumption of legal and illegal drugs by 11-16-year-old adolescent pupils. Findings from a study conducted under the auspices of the WHO Europe. Lausanne, Swiss Professional Service for Alcohol Problems, 1991.
28.
Buchmann AF, Laucht M, Schmid B, Wiedemann K, Mann K, Zimmermann US: Cigarette craving increases after a psychosocial stress test and is related to cortisol stress response but not to dependence scores in daily smokers. J Psychopharmacol 2010;24:247-255.
29.
Räikkönen K, Pesonen AK: Early life origins of psychological development and mental health. Scand J Psychol 2009;50:583-591.
30.
Gluckman PD, Hanson MA, Cooper C, Thornburg KL: Effect of in utero and early life conditions on adult health and disease. N Engl J Med 2008;359:61-73.
31.
Entringer S, Epel ES, Kumsta R, Lin J, Hellhammer DH, Blackburn EH, Wüst S, Wadhwa PD: Stress exposure in intrauterine life is associated with shorter telomere length in young adulthood. Proc Natl Acad Sci USA 2011;108:E513-E518.
32.
Huxley R, Neil A, Collins R: Unravelling the fetal origins hypothesis: is there really an inverse association between birthweight and subsequent blood pressure? Lancet 2002;360:659-665.
33.
Jaddoe VWV, Witteman JC: Hypotheses on fetal origins of adult diseases: contributions of epidemiological studies. Eur J Epidemiol 2006;21:91-102.
34.
Armitage JA, Poston L, Taylor PD: Developmental origins of obesity and the metabolic syndrome: the role of maternal obesity. Front Horm Res 2008;36:73-84.
35.
Franzek EJ, Sprangers N, Janssens AC, Van Duijn CM, Van De Wetering BJ: Prenatal exposure to the 1944-45 Dutch ‘hunger winter' and addiction later in life. Addiction 2008;103:433-438.
36.
Kanaka-Gantenbein C: Fetal origins of adult diabetes. Ann NY Acad Sci 2010;1205:99-105.
37.
Gubhaju L, Sutherland MR, Black MJ: Preterm birth and the kidney: implications for long-term renal health. Reprod Sci 2011;18:322-333.
38.
van Abeelen AF, Elias SG, Bossuyt PM, Grobbee DE, van der Schouw YT, Roseboom TJ, Uiterwaal CS: Cardiovascular consequences of famine in the young. Eur Heart J 2012;33:538-545.
39.
Vignini A, Raffaelli F, Cester A, Iannilli A, Cherubini V, Mazzanti L, Nanetti L: Environmental and genetical aspects of the link between pregnancy, birth size, and type 2 diabetes. Curr Diabetes Rev 2012;8:155-161.
40.
Poston L: Gestational weight gain: influences on the long-term health of the child. Curr Opin Clin Nutr Metab Care 2012;15:252-257.
41.
Turner S: Perinatal programming of childhood asthma: early fetal size, growth trajectory during infancy, and childhood asthma outcomes. Clin Dev Immunol 2012;2012:962923.
42.
Waterland RA, Michels KB: Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr 2007;27:363-388.
43.
Wadhwa PD, Buss C, Entringer S, Swanson JM: Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med 2009;27:358-368.
44.
Duijts L: Fetal and infant origins of asthma. Eur J Epidemiol 2012;27:5-14.
45.
Martínez JA, Cordero P, Campión J, Milagro FI: Interplay of early-life nutritional programming on obesity, inflammation and epigenetic outcomes. Proc Nutr Soc 2012;71:276-283.
46.
Vickers MH: Developmental programming of the metabolic syndrome - critical windows for intervention. World J Diabetes 2011;2:137-148.
47.
Fernandez-Fernandez R, Tena-Sempere M, Navarro VM, Barreiro ML, Castellano JM, Aguilar E, Pinilla L: Effects of ghrelin upon gonadotropin-releasing hormone and gonadotropin secretion in adult female rats: in vivo and in vitro studies. Neuroendocrinology 2005;82:245-255.
48.
Martini AC, Fernandez-Fernandez R, Tovar S, Navarro VM, Vigo E, Vazquez MJ, Davies JS, Thompson NM, Aguilar E, Pinilla L, Wells T, Dieguez C, Tena-Sempere M: Comparative analysis of the effects of ghrelin and unacylated ghrelin on luteinizing hormone secretion in male rats. Endocrinology 2006;147:2374-2382.
49.
Vulliemoz NR, Xiao E, Xia-Zhang L, Germond M, Rivier J, Ferin M: Decrease in luteinizing hormone pulse frequency during a five-hour peripheral ghrelin infusion in the ovariectomized rhesus monkey. J Clin Endocrinol Metab 2004;89:5718-5723.
50.
Iqbal J, Kurose Y, Canny B, Clarke IJ: Effects of central infusion of ghrelin on food intake and plasma levels of growth hormone, luteinizing hormone, prolactin, and cortisol secretion in sheep. Endocrinology 2006;147:510-519.
51.
Kluge M, Schussler P, Uhr M, Yassouridis A, Steiger A: Ghrelin suppresses secretion of luteinizing hormone in humans. J Clin Endocrinol Metab 2007;92:3202-3205.
52.
Lanfranco F, Bonelli L, Baldi M, Me E, Broglio F, Ghigo E: Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis. J Clin Endocrinol Metab 2008;93:3633-3639.
53.
Kluge M, Uhr M, Bleninger P, Yassouridis A, Steiger A: Ghrelin suppresses secretion of FSH in males. Clin Endocrinol 2009;70:920-923.
54.
Kluge M, Schüssler P, Schmidt D, Uhr M, Steiger A: Ghrelin suppresses secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in women. J Clin Endocrinol Metab 2012;97:E448-E451.
55.
Steiger A, Dresler M, Schüssler P, Kluge M: Ghrelin in mental health, sleep, memory. Mol Cell Endocrinol 2011;340:88-96.
56.
Barkan AL, Dimaraki EV, Jessup SK, Symons KV, Ermolenko M, Jaffe CA: Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J Clin Endocrinol Metab 2003;88:2180-2184.
57.
Chan JL, Bullen J, Lee JH, Yiannakouris N, Mantzoros CS: Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects. J Clin Endocrinol Metab 2004;89:335-343.
58.
Kluge M, Schussler P, Schmid D, Uhr M, Kleyer S, Yassouridis A, Steiger A: Ghrelin plasma levels are not altered in major depression. Neuropsychobiology 2009;59:199-204.
59.
Nakazato M, Hashimoto K, Shiina A, Koizumi H, Mitsumoti M, Imai M, Shimizu E, Iyo M: No changes in serum ghrelin levels in female patients with bulimia nervosa. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:1181-1184.
60.
Pöykkö SM, Kellokoski E, Ukkola O, Kauma H, Päivänsalo M, Kesäniemi YA, Hörkkö S: Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males. J Intern Med 2006;260:43-52.
61.
Kokkinos A, Tentolouris N, Kyriakaki E, Argyrakopoulou G, Doupis J, Psallas M, Kyriaki D, Katsilambros N: Differentiation in the short- and long-term effects of smoking on plasma total ghrelin concentrations between male nonsmokers and habitual smokers. Metabolism 2007;56:523-527.
62.
Schanze A, Reulbach U, Scheuchenzuber M, Groschl M, Kornhuber J, Kraus T: Ghrelin and eating disturbances in psychiatric disorders. Neuropsychobiology 2008;57:126-130.
63.
Bouros D, Tzouvelekis A, Anevlavis S, Doris M, Tryfon S, Froudarakis M, Zournatzi V, Kukuvitis A: Smoking acutely increases plasma ghrelin concentrations. Clin Chem 2006;52:777-778.
64.
Lee H, Joe KH, Kim W, Park J, Lee DH, Sung KW, Kim DJ: Increased leptin and decreased ghrelin level after smoking cessation. Neurosci Lett 2006;409:47-51.
65.
Ward C, Lewis S, Coleman T: Prevalence of maternal smoking and environmental tobacco smoke exposure during pregnancy and impact on birth weight: retrospective study using Millennium Cohort. BMC Public Health 2007;7:81.
66.
Chiolero A, Bovet P, Paccaud F: Association between maternal smoking and low birth weight in Switzerland: the EDEN study. Swiss Med Wkly 2005;135:525-530.
67.
Bernstein IM, Mongeon JA, Badger GJ, Solomon L, Heil SH, Higgins ST: Maternal smoking and its association with birth weight. Obstet Gynecol 2005;106:986-991.
68.
von Kries R, Toschke AM, Koletzko B, Slikker W Jr: Maternal smoking during pregnancy and childhood obesity. Am J Epidemiol 2002;156:954-961.
69.
Widerøe M, Vik T, Jacobsen G, Bakketeig LS: Does maternal smoking during pregnancy cause childhood overweight? Paediatr Perinat Epidemiol 2003;17:171-179.
70.
Williams DL, Cummings DE: Regulation of ghrelin in physiologic and pathophysiologic states. J Nutr 2005;135:1320-1325.
71.
Blom WA, Lluch A, Stafleu A, Vinoy S, Holst JJ, Schaafsma G, Hendriks HF: Effect of a high-protein breakfast on the postprandial ghrelin response. Am J Clin Nutr 2006;83:211-220.
72.
Giovino GA: The tobacco epidemic in the United States. Am J Prev Med 2007;33:318-326.
73.
NHS Scotland, Information Services Division. Births and Babies: Smoking and Pregnancy. 2009. www.isdscotland.org/isd/2911.html.
74.
Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S: The validity of self-reported smoking: a review and meta-analysis. Am J Public Health1994;84:1086-1093.
75.
Shipton D, Tappin DM, Vadiveloo T, Crossley JA, Aitken DA, Chalmers J: Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study. BMJ 2009;339:b4347.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.